Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer

NCT01452724 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Duodenal Ulcer

Interventions

DRUG: TAK-438
DRUG: Placebo
DRUG: Lansoprazole
DRUG: Placebo

Sponsor

Takeda